ADAR1 Capital Management, LLC: 13F holdings
CIK 19402722026Q2
| Positions | 272 |
|---|
| Reported value | $2.2bn |
|---|
| Filed | 2026-08-14 |
|---|
Change since last quarter
| Positions | 272 (-28 vs prior quarter) |
|---|
| Reported value | $2.2bn (+28.8%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| ABVX ABIVAX SA | 1,804,703 | $240.5m | 11.0% |
| PTGX PROTAGONIST THERAPEUTICS INC | 960,863 | $117.8m | 5.4% |
| ROIVANT SCIENCES LTD | 3,157,008 | $111.7m | 5.1% |
| SPY STATE STR SPDR S&P 500 ETF T | 129,087 | $96.4m | 4.4% |
| IMVT IMMUNOVANT INC | 2,330,716 | $89.8m | 4.1% |
| ZLAB ZAI LAB LTD | 3,369,034 | $64.0m | 2.9% |
| AGIO AGIOS PHARMACEUTICALS INC | 1,288,053 | $47.8m | 2.2% |
| CRINETICS PHARMACEUTICALS IN | 1,222,080 | $45.7m | 2.1% |
| BOXX EA SERIES TRUST | 337,125 | $39.5m | 1.8% |
| CYTK CYTOKINETICS INC | 457,907 | $39.0m | 1.8% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1940272")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples